Aduhelm FDA Controversy
-
Drug News
Controversy Trails Aduhelm Approval By FDA
Controversy continues to trail the United States Food and Drug Administration’s approval of Biogen’s aducanumab. Aducanumab, sold under the brand…
Read More »
Controversy continues to trail the United States Food and Drug Administration’s approval of Biogen’s aducanumab. Aducanumab, sold under the brand…
Read More »